Search Results - "Makar, M S"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Enhancement of the radiation response of EMT-6 tumours by a copper octabromotetracarboranylphenylporphyrin by MIURA, M, MORRIS, G. M, HOPEWELL, J. W, MICCA, P. L, MAKAR, M. S, NAWROCKY, M. M, RENNER, M. W

    Published in British journal of radiology (01-04-2012)
    “…The carborane-containing porphyrin, copper (II) 2,3,7,8,12,13,17,18-octabromo-5,10,15,20-tetrakis(3-[1,2-dicarba-closo-dodecaboranyl]methoxyphenyl)-porphyrin…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Synthesis of copper octabromotetracarboranylphenylporphyrin for boron neutron capture therapy and its toxicity and biodistribution in tumour-bearing mice by MIURA, M, MORRIS, G. M, MICCA, P. L, NAWROCKY, M. M, MAKAR, M. S, COOK, S. P, SLATKIN, D. N

    Published in British journal of radiology (01-07-2004)
    “…Copper tetracarboranyltetraphenylporphyrin (CuTCPH) is a minimally toxic carborane-containing porphyrin that has safely delivered high concentrations of boron…”
    Get full text
    Journal Article
  4. 4

    Derivations of relative biological effectiveness for the high-let radiations produced during boron neutron capture irradiations of the 9L rat gliosarcoma in vitro and in vivo by Coderre, J A, Makar, M S, Micca, P L, Nawrocky, M M, Liu, H B, Joel, D D, Slatkin, D N, Amols, H I

    “…Relative biological effectiveness (RBE) values for the high linear-energy-transfer particles produced during boron neutron capture therapy have generally been…”
    Get more information
    Journal Article
  5. 5

    Accumulation of Boron in Malignant and Normal Cells Incubated In Vitro with Boronophenylalanine, Mercaptoborane or Boric Acid by Capala, Jacek, Makar, Michael S., Coderre, Jeffrey A.

    Published in Radiation research (01-11-1996)
    “…The short (<10 μm) ranges of α and ^{7}{\rm Li}$ particles produced during boron neutron capture therapy (BNCT) make the partitioning of the boronated drug…”
    Get full text
    Journal Article
  6. 6

    Sudden Cardiac Death Among Hemodialysis Patients by Makar, Melissa S., MD, Pun, Patrick H., MD, MHS

    Published in American journal of kidney diseases (01-05-2017)
    “…Hemodialysis patients carry a large burden of cardiovascular disease; most onerous is the high risk for sudden cardiac death. Defining sudden cardiac death…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Postoperative Communication Volume Following Total Joint Arthroplasty Can Be a Precursor for Emergency Department Visits by Ozdag, Yagiz, Makar, Gabriel S., Kolessar, David J.

    Published in Arthroplasty today (01-06-2024)
    “…Unplanned calls, messages, and visits to the clinic can occur at a higher rate as newer technologies allow patients more accessibility and connectivity to…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Synthesis, toxicity and biodistribution of two 5,15-di[3,5-( nido-carboranylmethyl)phenyl]porphyrins in EMT-6 tumor bearing mice by Vicente, M.Graça H, Wickramasinghe, Anura, Nurco, Daniel J, Wang, Hong J.H, Nawrocky, Marta M, Makar, Michael S, Miura, Michiko

    Published in Bioorganic & medicinal chemistry (17-07-2003)
    “…The total synthesis of a 5,15-di[3,5-( o-carboranylmethyl)phenyl]porphyrin 5, its zinc(II) complex 6, and the corresponding nido-carboranylporphyrins 7 and 8…”
    Get full text
    Journal Article
  11. 11

    Medicolegal liability in laboratory medicine by Dighe, Anand S., MD, Makar, Robert S., MD, Lewandrowski, Kent B., MD

    Published in Seminars in diagnostic pathology (01-05-2007)
    “…The laboratory testing process, including the preanalytic, analytic, and postanalytic phases, is an area where errors frequently occur. These errors may impair…”
    Get full text
    Journal Article